Ejaimo IV infusion 1.1g, from Sanofi, features Stimulimab (genetical recombination). This injectable drug (YJ code: 6399431A1023) is provided as 1.1g in 22mL per bottle. It is a novel therapeutic antibody designed to modulate specific immune pathways.
Ejaimo IV infusion 1.1g
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).